Local anasthetics Varaint B

Question: Define local anesthetics (LAs) and describe their primary clinical applications.

Answer: LAs are drugs that reversibly suppress the generation and conduction of nerve impulses along afferent fibers, causing a loss of sensation in a limited area without loss of consciousness. They are used in surgery, dentistry, obstetrics (labor analgesia), regional anesthesia, minor procedures, pain management, and endoscopy. Lidocaine also serves as a Class Ib antiarrhythmic.

---

Question: What is the common chemical architecture shared by all local anesthetics, and how are they classified based on this structure?

Answer: They all consist of a lipophilic aromatic ring, an intermediate chain, and a hydrophilic tertiary amine. Based on the bond in the intermediate chain, they are classified into Esters (contain an –COO– bond) and Amides (contain an –NHCO– bond).

---

Question: Classify local anesthetics by their chemical structure (Esters vs. Amides) and provide examples for each.

Answer: Esters: Cocaine, Benzocaine, Procaine, Tetracaine, Chloroprocaine. Amides: Dibucaine, Lidocaine, Mepivacaine, Prilocaine, Bupivacaine, Etidocaine, Ropivacaine, Levobupivacaine, and Articaine (a hybrid amide with a thiophene ring and ester side chain).

---

Question: Classify local anesthetics based on their duration of action, providing examples for each category.

Answer: Short-acting: Procaine, Chloroprocaine (Esters). Medium-acting: Lidocaine, Prilocaine, Mepivacaine (Amides). Long-acting: Tetracaine, Benzocaine (Esters); Bupivacaine, Etidocaine, Ropivacaine, Levobupivacaine (Amides).

---

Question: Describe the structure of the voltage-gated Na⁺ channel targeted by local anesthetics.

Answer: It is a complex multimeric structure consisting of one α-subunit (containing four domains I–IV, each with six transmembrane segments S1–S6) linked to one or two β-subunits. Together, they form the ion-conducting channel pore.

---

Question: Explain the mechanism of action of local anesthetics at the cellular level.

Answer: The non-ionized, lipophilic form diffuses through the neuronal membrane. Inside the cell, it re-ionizes and binds to the receptor site in domain IV, segment S6 of the α-subunit from the cytoplasmic side (only when the channel is open). This blocks Na⁺ entry, preventing depolarization and action potential propagation, while leaving the resting membrane potential unchanged.

---

Question: Explain the "use-dependent" (phasic) block of local anesthetics.

Answer: LAs have a higher affinity for open and inactivated Na⁺ channels than for resting ones. Therefore, rapidly firing fibers (e.g., nociceptors, ischemic or arrhythmic cardiac cells) are blocked first and most strongly by the drug.

---

Question: How do pKa and tissue pH affect the onset of action and efficacy of local anesthetics?

Answer: A lower pKa means more non-ionized drug at pH 7.4, leading to a faster onset. In acidic (infected/inflamed) tissue, more drug remains ionized outside the cell, reducing membrane penetration and efficacy. Adding sodium bicarbonate raises the solution's pH, speeding up onset and reducing injection pain.

---

Question: What is "ion trapping" in the context of local anesthesia, and why is it clinically relevant?

Answer: In fetal acidosis, the non-ionized drug crosses the placenta and becomes ionized (trapped) in the more acidic fetal blood, which can lead to fetal toxicity. This is highly relevant in obstetric anesthesia.

---

Question: Explain the concept of a differential (selective) nerve block and the order in which nerve fibers are affected.

Answer: LAs preferentially block small, myelinated fibers. The order of loss is: Sympathetic (B fibers) → temperature and sharp pain (Aδ, C fibers) → touch and pressure (Aβ fibers) → motor function (Aα fibers). Recovery occurs in the reverse order, meaning patients may still feel pressure while reporting no pain.

---

Question: How do local anesthetics affect potassium (K⁺) and calcium (Ca²⁺) channels?

Answer: LAs weakly block K⁺ channels, slowing repolarization and prolonging depolarization (contributing to QT prolongation and arrhythmias in the heart). They also inhibit N- and P-type Ca²⁺ channels (weaker than Na⁺ blockade), reducing neurotransmitter release and contributing to cardiotoxicity.

---

Question: Beyond Na⁺ channel blockade, what other pharmacological properties do local anesthetics exhibit?

Answer: They inhibit G-protein-coupled receptors (NK-1, B2, ETA), modulate TRPV1 sensory receptors, exert anti-inflammatory effects (reducing ERK1/2 signaling), and show antiproliferative/apoptotic and antibacterial/antifungal activity.

---

Question: How does the site of injection affect the systemic absorption of local anesthetics?

Answer: Absorption depends on the vascularity of the site. From highest to lowest, the order is: IV > tracheal > intercostal > paracervical > caudal > epidural > brachial plexus > sciatic/femoral > subcutaneous.

---

Question: How does protein binding influence the pharmacokinetics and toxicity of local anesthetics?

Answer: LAs bind mainly to α1-acid glycoprotein and albumin. Higher protein binding (e.g., bupivacaine) correlates with a longer duration of action. The unbound (free) fraction is what causes toxicity. All LAs cross the placenta and diffuse into breast milk.

---

Question: Compare the metabolism and excretion of ester versus amide local anesthetics.

Answer: Esters are rapidly hydrolyzed in the plasma by pseudocholinesterase to PABA and an alcohol. Amides are metabolized in the liver by CYP enzymes. Articaine is unique as an amide hydrolyzed in both plasma and tissues. Both are mostly excreted renally as metabolites.

---

Question: What factors can prolong the half-life of amide local anesthetics?

Answer: Reduced hepatic blood flow (e.g., heart failure, use of β-blockers) or liver disease, because amides undergo hepatic metabolism.

---

Question: Describe the structure-activity relationships that determine the properties of local anesthetics.

Answer: Lipid solubility determines potency (bupivacaine > lidocaine > procaine). Protein binding determines duration. pKa determines onset speed. Vasodilator activity speeds absorption and shortens the effect (except for cocaine, which is a vasoconstrictor).

---

Question: Compare esters and amides in terms of safety, stability, and cross-reactivity.

Answer: Esters have a higher risk of allergic reactions (due to the PABA metabolite), are unstable in solution, and have cross-reactivity among themselves. Amides are usually safer, rarely cause true allergies, are very stable (can be autoclaved), and have no cross-reactivity with esters.

---

Question: Why is epinephrine added to local anesthetic solutions, and what are its benefits?

Answer: Epinephrine causes local vasoconstriction. This prolongs the duration of action, reduces peak plasma concentration and systemic toxicity, improves the quality of the block, and reduces bleeding at the surgical site (hemostasis).

---

Question: When is epinephrine contraindicated or used with caution in local anesthetic solutions?

Answer: It is relatively contraindicated in end-arterial areas (fingers, toes, penis, nose, ear lobe) due to the risk of ischemic necrosis. It should be used with caution in uncontrolled hypertension, ischemic heart disease, arrhythmias, hyperthyroidism, and with MAO inhibitors or tricyclic antidepressants.

---

Question: Why do epinephrine-containing local anesthetic solutions have a slower onset and cause more pain on injection?

Answer: These solutions are acidified (pH ≈ 3–4.5) with sodium metabisulfite. The acidity increases the ionized fraction of the LA (slower onset) and the metabisulfite can cause pain and a risk of sulfite allergy.

---

Question: What are the standard maximum recommended doses for Lidocaine and Bupivacaine in healthy adults?

Answer: Lidocaine: 4.5 mg/kg (max 300 mg) without epinephrine; 7 mg/kg (max 500 mg) with epinephrine. Bupivacaine: 2 mg/kg (max 175 mg) without epinephrine; max 225 mg with epinephrine (≤400 mg per 24 h).

---

Question: List the various techniques (methods) used for local anesthesia administration.

Answer: Surface/topical, infiltration, peripheral nerve block, intravenous regional (Bier block), epidural and caudal, spinal/subarachnoid, and tumescent anesthesia.

---

Question: What are the primary uses and major adverse effect of Benzocaine?

Answer: Benzocaine is used for terminal (surface) anesthesia (e.g., sore throat, dental procedures). Its major adverse effect is methemoglobinemia, especially in children and the elderly.

---

Question: What is the clinical use of Procaine, and what is its unique caution regarding its metabolite?

Answer: Procaine is used for infiltration and nerve-block anesthesia. Its PABA metabolite can cause allergic reactions and antagonizes the antibacterial effect of sulfonamides.

---

Question: What are the primary uses of Tetracaine and Chloroprocaine, and why does Chloroprocaine have very low systemic toxicity?

Answer: Tetracaine is used for ophthalmology (eye drops) and spinal anesthesia. Chloroprocaine is used for infiltration, peripheral blocks, and epidural anesthesia (including urgent C-sections); its extremely rapid plasma hydrolysis (t½ < 1 min) gives it very low systemic toxicity.

---

Question: What is the unique chemical structure of Articaine, and how does it affect its half-life?

Answer: It is a hybrid amide containing a thiophene ring and an additional ester side chain. It is hydrolyzed in both plasma and tissues, giving it a short half-life of approximately 27 minutes.

---

Question: Which local anesthetic causes vasoconstriction instead of vasodilation, and what is the mechanism?

Answer: Cocaine, because it blocks the reuptake of norepinephrine and dopamine, making it the only LA that causes vasoconstriction.

---

Question: What is the clinical significance of the free fraction of a local anesthetic?

Answer: The unbound (free) fraction of the drug is pharmacologically active and determines systemic toxicity. Conditions that increase α1-acid glycoprotein (like inflammation) can bind more drug, potentially reducing the free fraction and toxicity risk.

---

Question: Which local anesthetic carries the highest risk of cardiotoxicity, and what is the mechanism?

Answer: Bupivacaine carries the highest risk. It potently blocks cardiac Na⁺ channels and also affects K⁺ and Ca²⁺ channels, making accidental intravascular injection particularly dangerous.

---

Question: What other additives (besides epinephrine) can be combined with local anesthetics, and what are their purposes?

Answer: Sodium bicarbonate (raises pH, speeds onset), clonidine and dexmedetomidine (prolong block), opioids like fentanyl/morphine (neuraxial anesthesia), dexamethasone (peripheral nerve blocks), and hyaluronidase.

---

Question: Why do local anesthetics work poorly in an abscess (infected tissue)?

Answer: The acidic environment in an abscess causes more of the drug to remain in the ionized form outside the cell. Since only the non-ionized form can cross the neuronal membrane, the effectiveness of the anesthesia is significantly reduced.

---

Question: How do local anesthetics affect G-protein-coupled receptors and sensory receptors?

Answer: They inhibit G-protein-coupled receptors involved in nociceptive and inflammatory reactions (substance P NK-1, bradykinin B2, endothelin-1 ETA) and modulate sensory receptors like TRPV1, contributing to their analgesic and anti-inflammatory effects.

---

Question: What is the role of α1-acid glycoprotein in the pharmacokinetics of local anesthetics?

Answer: It is the main binding protein for LAs in the blood. High levels (e.g., in inflammation or cancer) can bind more drug, reducing the free fraction and potentially decreasing the risk of systemic toxicity.

---

Question: Compare the systemic toxicity of esters versus amides.

Answer: Esters generally have lower systemic toxicity because they are rapidly hydrolyzed by plasma esterases (except cocaine). Amides have higher systemic toxicity, especially bupivacaine, due to their slower hepatic metabolism.

---

Question: Give a comprehensive summary of the entire local anesthetic classification system, including structure, duration, and examples.

Answer: LAs are classified by structure into Esters (Cocaine, Benzocaine, Procaine, Tetracaine, Chloroprocaine) and Amides (Lidocaine, Mepivacaine, Prilocaine, Bupivacaine, Ropivacaine, Articaine, etc.). By duration, they are Short (Procaine, Chloroprocaine), Medium (Lidocaine, Prilocaine, Mepivacaine), and Long (Tetracaine, Bupivacaine, Ropivacaine). Amides are metabolized hepatically and are more stable; esters are hydrolyzed by plasma esterases and carry a higher allergy risk.